Ben Jenkins
@ben-j-jenkins.bsky.social
Imiwnolegydd Cymraeg 🏴 • Post Doc @ Swansea University in Nick Jones' group • Interested in #immunometabolism and disease, currently focussing on T cells
Thank you, Andy!
November 3, 2025 at 8:11 PM
Thank you, Andy!
Reposted by Ben Jenkins
Secondly, PhD student Emma Lucas and myself contributed towards how metabolism shapes relapsed/refractory T-cell acute lymphoblastic leukaemia, led by João Barata and colleagues from the T-ALL special interest group
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemia - Leukemia
Leukemia - Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemia
www.nature.com
August 14, 2025 at 7:26 PM
Secondly, PhD student Emma Lucas and myself contributed towards how metabolism shapes relapsed/refractory T-cell acute lymphoblastic leukaemia, led by João Barata and colleagues from the T-ALL special interest group
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Reposted by Ben Jenkins
The first takes a look at repurposing metabolic drugs as anti-inflammatory agents with @andyhogan82.bsky.social @ben-j-jenkins.bsky.social @obesityimmunology.bsky.social
www.cell.com/trends/endoc...
www.cell.com/trends/endoc...
Repurposing metabolic drugs as anti-inflammatory agents
Dysregulation of bodyweight systemic metabolism is intrinsically linked to an inflammatory
phenotype, with each underpinning the other. Over the past decade, new classes of
drug, such as glucagon-like...
www.cell.com
August 14, 2025 at 7:26 PM
The first takes a look at repurposing metabolic drugs as anti-inflammatory agents with @andyhogan82.bsky.social @ben-j-jenkins.bsky.social @obesityimmunology.bsky.social
www.cell.com/trends/endoc...
www.cell.com/trends/endoc...